{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:55:13Z","timestamp":1775609713080,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","giejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastrointestinal Endoscopy"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.gie.2010.09.022","type":"journal-article","created":{"date-parts":[[2010,12,9]],"date-time":"2010-12-09T10:10:14Z","timestamp":1291889414000},"page":"700-706.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Protease inhibitors for preventing complications associated with ERCP: an updated meta-analysis"],"prefix":"10.1016","volume":"73","author":[{"given":"Takeshi","family":"Seta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gie.2010.09.022_bib1","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0016-5107(02)70431-8","article-title":"Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial","volume":"56","author":"Andriulli","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2010.09.022_bib2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJM199609263351302","article-title":"Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography","volume":"335","author":"Cavallini","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gie.2010.09.022_bib3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S1542-3565(04)00671-8","article-title":"Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial","volume":"3","author":"Tsujino","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gie.2010.09.022_bib4","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/MPA.0b013e31817f528f","article-title":"Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo-controlled trial","volume":"37","author":"Yoo","year":"2008","journal-title":"Pancreas"},{"key":"10.1016\/j.gie.2010.09.022_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0016-5107(00)70377-4","article-title":"Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis","volume":"51","author":"Andriulli","year":"2000","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2010.09.022_bib6","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.gie.2006.10.030","article-title":"Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis","volume":"65","author":"Andriulli","year":"2007","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2010.09.022_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-230X-7-6","article-title":"Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials","volume":"7","author":"Zheng","year":"2007","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.gie.2010.09.022_bib8","doi-asserted-by":"crossref","DOI":"10.1097\/MPA.0b013e3181dc67e7","article-title":"Role of ulinastatin in preventing post-Endoscopic retrograde cholangiopancreatography pancreatitis","author":"Chen","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.gie.2010.09.022_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.gie.2010.09.022_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2307\/2530643","article-title":"Estimation of a common effect parameter from sparse follow-up data","volume":"41","author":"Greenland","year":"1985","journal-title":"Biometrics"},{"key":"10.1016\/j.gie.2010.09.022_bib11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analysis","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.gie.2010.09.022_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.gie.2010.09.022_bib13","series-title":"Summing up: the science of reviewing research","author":"Light","year":"1984"},{"key":"10.1016\/j.gie.2010.09.022_bib14","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.gie.2010.09.022_bib15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.gie.2010.09.022_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0016-5107(77)73457-1","article-title":"Pancreatic injury following ERCP","volume":"24","author":"Brust","year":"1977","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2010.09.022_bib17","first-page":"1375","article-title":"Effect of FOY on hyperamylasemia after endoscopic retrograde cholangiopancreatography","volume":"10","author":"Hajiro","year":"1978","journal-title":"Gendai Iryo"},{"key":"10.1016\/j.gie.2010.09.022_bib18","first-page":"571","article-title":"Study on prevention of complication associated with endoscopic retrograde cholangiopancreatography ERCP): a controlled trial of a new protease inhibitor, FOY, in hyperamylasemia following endoscopic retrograde cholangiopancreatography","volume":"10","author":"Kuno","year":"1978","journal-title":"Gendai Iryo"},{"key":"10.1016\/j.gie.2010.09.022_bib19","first-page":"540","article-title":"Prophylactic effects of preoperative administration of Gabexate Mesilate (FOY) on post-ERCP pancreatitis","volume":"11","author":"Shimizu","year":"1979","journal-title":"Gendai Iryo"},{"key":"10.1016\/j.gie.2010.09.022_bib20","first-page":"A165","article-title":"Effect of a new enzyme inhibitor (Gabexate Mesilate- FOY) on hyperenzymemia induced by ERCP","volume":"32","author":"Benini","year":"1985","journal-title":"Digestion"},{"key":"10.1016\/j.gie.2010.09.022_bib21","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1542-3565(04)00295-2","article-title":"Prophylaxis of ERCP- related pancreatitis; a randomized, controlled trial of somatostatin and gabexate mesilate","volume":"2","author":"Andriulli","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gie.2010.09.022_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1590\/S0100-879X2006000100010","article-title":"Clinical trial of gabexate in the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis","volume":"39","author":"Xiong","year":"2006","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.gie.2010.09.022_bib23","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S1590-8658(06)80037-X","article-title":"Prevention of post-ERCP pancreatitis with somatostatin versus gabexate mesilate: a randomized placebo-controlled multicenter study","volume":"38","author":"Benvenuti","year":"2006","journal-title":"Dig Liv Dis"},{"key":"10.1016\/j.gie.2010.09.022_bib24","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.gie.2007.02.055","article-title":"Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study","volume":"65","author":"Manes","year":"2007","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2010.09.022_bib25","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.gie.2008.10.046","article-title":"Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis","volume":"69","author":"Choi","year":"2009","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2010.09.022_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00535-006-1986-8","article-title":"Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized trial","volume":"42","author":"Ueki","year":"2007","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.gie.2010.09.022_bib27","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1440-1746.2006.04085.x","article-title":"Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study","volume":"21","author":"Fujishiro","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.gie.2010.09.022_bib28","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1111\/j.1572-0241.2003.07698.x","article-title":"Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis","volume":"98","author":"Masci","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gie.2010.09.022_bib29","first-page":"688","article-title":"Effect of secretin and gabexate-mesilate (synthetic protease inhibitor) on serum amylase level after ERCP","volume":"20","author":"Tympner","year":"1982","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.gie.2010.09.022_bib30","first-page":"554","article-title":"Increased serum trypsinogen 2 and trypsin 2-1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography (ERCP)-induced pancreatitis with high accuracy","volume":"47","author":"Baillie","year":"1998","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2010.09.022_bib31","first-page":"851","article-title":"Does gabexate mesilate affect serum concentrations of acute phase proteins after endoscopic retrograde cholangiopancreatography examination?","volume":"50","author":"Pezzilli","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.gie.2010.09.022_bib32","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1440-1746.2007.04928.x","article-title":"Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials","volume":"22","author":"Rudin","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.gie.2010.09.022_bib33","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00000658-200011000-00001","article-title":"Acute necrotizing pancreatitis: treatment strategy according to the status of infection","volume":"232","author":"B\u00fcchler","year":"2000","journal-title":"Ann Surg"},{"key":"10.1016\/j.gie.2010.09.022_bib34","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0016-5107(03)02000-5","article-title":"Short-term prophylactic prevention of post-ERCP pancreatitis","volume":"58","author":"Masci","year":"2003","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2010.09.022_bib35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/jso.21098","article-title":"Randomized clinical trial to assess the efficacy of ulinastatin for postoperative pancreatitis following pancreaticoduodenectomy","volume":"98","author":"Uemura","year":"2008","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.gie.2010.09.022_bib36","series-title":"Proteinase-inhibition, FOY workshop, 1981","first-page":"132","article-title":"Wirkung des synthetischen proteinase-inhibitors FOY auf die hyperamylasamie nach ERP","author":"Salamon","year":"1982"},{"key":"10.1016\/j.gie.2010.09.022_bib37","first-page":"101","article-title":"Prevention and treatment for post ERCP pancreatitis","volume":"12","author":"Gong","year":"2004","journal-title":"J Hepatobiliary Surg"},{"key":"10.1016\/j.gie.2010.09.022_bib38","first-page":"24","article-title":"Prevention effects of ulinastatin on post ERCP hyperamylasemia and acute pancreatitis","volume":"31","author":"Song","year":"2005","journal-title":"J Lanzhou Univ (Med Sci)"},{"key":"10.1016\/j.gie.2010.09.022_bib39","first-page":"44","article-title":"Clinical observation on ulinastatin for the prevention of post-ERCP pancreatitis","volume":"45","author":"Chen","year":"2005","journal-title":"Shandong Med J"},{"key":"10.1016\/j.gie.2010.09.022_bib40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1254\/jjp.41.155","article-title":"Pharmacological studies of FUT-175, nafamostat mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats","volume":"41","author":"Iwaki","year":"1986","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.gie.2010.09.022_bib41","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJM199609263351301","article-title":"Complications of endoscopic biliary sphincterotomy","volume":"335","author":"Freeman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gie.2010.09.022_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0016-5107(98)70121-X","article-title":"Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study","volume":"48","author":"Loperfido","year":"1998","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2010.09.022_bib43","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1572-0241.2001.03594.x","article-title":"Complications of diagnostic and therapeutic ERCP: a prospective multicenter study","volume":"96","author":"Masci","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gie.2010.09.022_bib44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1067\/mge.2001.117550","article-title":"Risk factors for post-ERCP pancreatitis: a prospective, multicenter study","volume":"54","author":"Freeman","year":"2001","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2010.09.022_bib45","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1111\/j.1572-0241.2007.01279.x","article-title":"Incidence rates of post-ERCP complications: a systematic survey of prospective studies","volume":"102","author":"Andriulli","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gie.2010.09.022_bib46","first-page":"69","article-title":"Prognostic signs and the role of operative management in acute pancreatitis","volume":"139","author":"Ranson","year":"1974","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.gie.2010.09.022_bib47","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE: a severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care Med"}],"container-title":["Gastrointestinal Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001651071002105X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001651071002105X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:15:48Z","timestamp":1758039348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001651071002105X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S001651071002105X"],"URL":"https:\/\/doi.org\/10.1016\/j.gie.2010.09.022","relation":{},"ISSN":["0016-5107"],"issn-type":[{"value":"0016-5107","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protease inhibitors for preventing complications associated with ERCP: an updated meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Gastrointestinal Endoscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gie.2010.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}